واکسن کووید-۱۹ مدرنا (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "واکسن کووید-۱۹ مدرنا" in Persian language version.

refsWebsite

Global rank Persian rank

7web.archive.org

1^st place

5doi.org

2^nd place

5nih.gov

4^th place

5^th place

2cnbc.com

220^th place

283^rd place

2europa.eu

68^th place

179^th place

2fda.gov

447^th place

382^nd place

1idsociety.org

low place

1cdc.gov

218^th place

126^th place

1gov.uk

432^nd place

1,605^th place

1trackvaccines.org

low place

1businesswire.com

615^th place

1,007^th place

1reuters.com

49^th place

76^th place

1who.int

195^th place

129^th place

1aappublications.org

3,763^rd place

1,566^th place

1npr.org

92^nd place

276^th place

1medrxiv.org

low place

1worldcat.org

5^th place

12^th place

1nejm.org

2,374^th place

2,531^st place

1cnn.com

28^th place

65^th place

1cvdvaccine-us.com

low place

1fortune.com

433^rd place

721^st place

1jakartaglobe.id

low place

aappublications.org

Jenco J (16 March 2021). "Moderna testing COVID-19 vaccine in children under 12". AAP News.

businesswire.com

"First Participants Dosed in Phase 1 Study Evaluating mRNA-1283, Moderna's Next Generation COVID-19 Vaccine" (Press release). Moderna. 15 March 2021 – via Business Wire.

cdc.gov

Oliver, Sara E.; Gargano, Julia W.; Marin, Mona; Wallace, Megan; Curran, Kathryn G.; Chamberland, Mary; et al. (December 2020). "The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020" (PDF). MMWR. Morbidity and Mortality Weekly Report. 69 (5152). doi:10.15585/mmwr.mm695152e1.

cnbc.com

Lovelace Jr, Berkeley (19 December 2020). "FDA approves second Covid vaccine for emergency use as it clears Moderna's for U.S. distribution". CNBC. Retrieved 19 December 2020.
Lovelace Jr, Berkeley; Higgins-Dunn, Noah (16 November 2020). "Moderna says preliminary trial data shows its coronavirus vaccine is more than 94% effective, shares soar". CNBC. Retrieved 17 November 2020.

cnn.com

Kuznia, Robert; Polglase, Katie; Mezzofiore, Gianluca (1 May 2020). "In quest for vaccine, US makes 'big bet' on company with unproven technology". CNN. Archived from the original on 2020-05-13. Retrieved 2020-05-02.

cvdvaccine-us.com

"Pfizer-BioNTech COVID-19 Vaccine Vaccination Storage & Dry Ice Safety Handling". Pfizer. Archived from the original on 24 January 2021. Retrieved 17 December 2020.

doi.org

Oliver, Sara E.; Gargano, Julia W.; Marin, Mona; Wallace, Megan; Curran, Kathryn G.; Chamberland, Mary; et al. (December 2020). "The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020" (PDF). MMWR. Morbidity and Mortality Weekly Report. 69 (5152). doi:10.15585/mmwr.mm695152e1.
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. (February 2021). "Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine". The New England Journal of Medicine. 384 (5): 403–416. doi:10.1056/NEJMoa2035389. PMC 7787219. PMID 33378609.
Doria-Rose N, Suthar MS, Makowski M, O'Connell S, McDermott AB, Flach B, et al. (June 2021). "Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19". N Engl J Med. 384 (23): 2259–2261. doi:10.1056/NEJMc2103916. PMID 33822494.
Chung, Hannah; He, Siyi; Nasreen, Sharifa; Sundaram, Maria E.; Buchan, Sarah A.; Wilson, Sarah E.; Chen, Branson; Calzavara, Andrew; Fell, Deshayne B. (2021-05-28). "Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes in Ontario, Canada". medRxiv (به انگلیسی): 2021.05.24.21257744. doi:10.1101/2021.05.24.21257744. ISSN 2125-7744.

dx.doi.org

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report, Lisa A. Jackson et al. , New England Journal of Medicine 383 (Nov. 12, 2020), pp. 1920-1931, doi:10.1056/NEJMoa2022483.

europa.eu

ec.europa.eu

"COVID-19 Vaccine Moderna". Union Register of medicinal products. Retrieved 14 January 2021.
"European Commission authorises second safe and effective vaccine against COVID-19" (Press release). Retrieved 6 January 2021.

fda.gov

"Vaccines and Related Biological Products Advisory Committee Meeting". Food and Drug Administration. 17 December 2020.
"VRBPAC mRNA-1273 Sponsor Briefing Document" (PDF). Moderna. 17 December 2020.

fortune.com

"How China's COVID-19 could fill the gaps left by Pfizer, Moderna, AstraZeneca". Fortune. 5 December 2020. Archived from the original on 12 December 2020. Retrieved 5 December 2020.

gov.uk

"Moderna vaccine becomes third COVID-19 vaccine approved by UK regulator". U.K. Government. 8 January 2021. Retrieved 8 January 2021.

idsociety.org

"Moderna COVID-19 Vaccine". Dosing & Administration. Infectious Diseases Society of America. 4 January 2021. Archived from the original on 20 December 2020. Retrieved 5 January 2021.

jakartaglobe.id

"Pfizer's Vaccine Is Out of the Question as Indonesia Lacks Refrigerators: State Pharma Boss". Jakarta Globe. 22 November 2020. Archived from the original on 7 December 2020. Retrieved 5 December 2020.

medrxiv.org

Chung, Hannah; He, Siyi; Nasreen, Sharifa; Sundaram, Maria E.; Buchan, Sarah A.; Wilson, Sarah E.; Chen, Branson; Calzavara, Andrew; Fell, Deshayne B. (2021-05-28). "Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes in Ontario, Canada". medRxiv (به انگلیسی): 2021.05.24.21257744. doi:10.1101/2021.05.24.21257744. ISSN 2125-7744.

nejm.org

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report, Lisa A. Jackson et al. , New England Journal of Medicine 383 (Nov. 12, 2020), pp. 1920-1931, doi:10.1056/NEJMoa2022483.

nih.gov

"Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine". US National Institutes of Health. 18 December 2020. Retrieved 19 December 2020.
"NIH clinical trial of investigational vaccine for COVID-19 begins". National Institutes of Health (NIH). 16 March 2020. Archived from the original on 19 March 2020. Retrieved 18 March 2020.

pubmed.ncbi.nlm.nih.gov

Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. (February 2021). "Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine". The New England Journal of Medicine. 384 (5): 403–416. doi:10.1056/NEJMoa2035389. PMC 7787219. PMID 33378609.
Doria-Rose N, Suthar MS, Makowski M, O'Connell S, McDermott AB, Flach B, et al. (June 2021). "Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19". N Engl J Med. 384 (23): 2259–2261. doi:10.1056/NEJMc2103916. PMID 33822494.

ncbi.nlm.nih.gov

Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. (February 2021). "Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine". The New England Journal of Medicine. 384 (5): 403–416. doi:10.1056/NEJMoa2035389. PMC 7787219. PMID 33378609.

npr.org

Wamsley, Laurel (30 June 2021). "Moderna Says Studies Show Its Vaccine Is Effective Against The Delta Variant". NPR. Retrieved 28 July 2021.

reuters.com

"Moderna begins testing next-generation coronavirus vaccine". Reuters. March 15, 2021. Retrieved June 15, 2021.

trackvaccines.org

covid19.trackvaccines.org

"COVID-19 Vaccine Tracker: Moderna: mRNA-1273". McGill University. Archived from the original on 13 December 2021. Retrieved 5 August 2021.

web.archive.org

"Moderna COVID-19 Vaccine". Dosing & Administration. Infectious Diseases Society of America. 4 January 2021. Archived from the original on 20 December 2020. Retrieved 5 January 2021.
"COVID-19 Vaccine Tracker: Moderna: mRNA-1273". McGill University. Archived from the original on 13 December 2021. Retrieved 5 August 2021.
"NIH clinical trial of investigational vaccine for COVID-19 begins". National Institutes of Health (NIH). 16 March 2020. Archived from the original on 19 March 2020. Retrieved 18 March 2020.
Kuznia, Robert; Polglase, Katie; Mezzofiore, Gianluca (1 May 2020). "In quest for vaccine, US makes 'big bet' on company with unproven technology". CNN. Archived from the original on 2020-05-13. Retrieved 2020-05-02.
"Pfizer-BioNTech COVID-19 Vaccine Vaccination Storage & Dry Ice Safety Handling". Pfizer. Archived from the original on 24 January 2021. Retrieved 17 December 2020.
"How China's COVID-19 could fill the gaps left by Pfizer, Moderna, AstraZeneca". Fortune. 5 December 2020. Archived from the original on 12 December 2020. Retrieved 5 December 2020.
"Pfizer's Vaccine Is Out of the Question as Indonesia Lacks Refrigerators: State Pharma Boss". Jakarta Globe. 22 November 2020. Archived from the original on 7 December 2020. Retrieved 5 December 2020.

who.int

apps.who.int

World Health Organization (2021). "Background document on the mRNA-1273 vaccine (Moderna) against COVID-19: background document to the WHO Interim recommendations for use of the mRNA-1273 vaccine (Moderna), 3 February 2021" (به انگلیسی). {{cite journal}}: Cite journal requires |journal= (help)

worldcat.org

Chung, Hannah; He, Siyi; Nasreen, Sharifa; Sundaram, Maria E.; Buchan, Sarah A.; Wilson, Sarah E.; Chen, Branson; Calzavara, Andrew; Fell, Deshayne B. (2021-05-28). "Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes in Ontario, Canada". medRxiv (به انگلیسی): 2021.05.24.21257744. doi:10.1101/2021.05.24.21257744. ISSN 2125-7744.